Increased IL-6 which leads to overactivation of signal transducer and activator of transcription 3, a transcriptional activator that has been shown to contribute to the tumorigenesis of HCC, has been demonstrated in patients with HCC and preclinical models (102,103). Here, IL6 is linked to hepatocellular carcinoma.